Clinical Trial Update: Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This update reports termination of a Phase 2 randomized study evaluating TAC-101 in combination with transcatheter arterial chemoembolization (TACE) versus TACE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TAC-101

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Advanced Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2022-04-15